“Hepatitis E”的搜索结果，显示 11-20 项，共有 12677 项

1. Untitled

   Page 1.

2. Untitled

   Page 1.

3. 肝移植- Therapies for hepatitis C - 妙佑医疗国际

   Therapies for hepatitis C. 打印. 妙佑医疗国际的医生对丙肝（一种由病毒攻击肝脏引起的感染）有很多治疗方法。如果肝炎导致您的肝脏严重受损，则可能需要进行肝脏移植 ...

4. 丙肝 - 症状与病因- 妙佑医疗国际

   Hepatitis C questions and answers for health professionals. Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm ...

5. 大肠杆菌- 症状与病因- 妙佑医疗国际

   大肠杆菌（E. coli）通常生活在健康人和动物的肠道内。大多数类型的 大肠杆菌 是无害的，或会引起相对短暂的腹泻。但少数菌株，如 大肠杆菌 O157:H7，会导致严重的胃 ...

6. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this research study is to improve our understanding of normal liver and gallbladder function and liver and gallbladder diseases ...

7. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. This study aims to compare the fatty acid composition of small sample of fat (visceral and subcutaneous) removed at the time of ...

8. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...

9. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the ...

10. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

    The purpose of this study is: To assess the efficacy of treatment with checkpoint inhibitors (Pembrolizumab or Nivolumab) in metastatic gastric and esophageal ...